Home / Candesartan / Austria
AT ATC C09CA06 · updated 2 Nov 2026
Candesartan shortage in Austria
Is there a Candesartan shortage in Austria?
Yes. As of 2 Nov 2026, 1 Candesartan product is reported short in Austria, the first since 8 Feb 2026. The company estimate for the return is 7 Feb 2029. Main reason: commercial decision or withdrawal.
Also short in Canada, Germany, Italy, Spain, Czechia, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Blopress 32 mg - Tabletten, 28 Stück | Cheplapharm Arzneimittel GmbH | 8 Feb 2026 | 7 Feb 2029 | Commercial decision or withdrawal Vorübergehende Einstellung des Inverkehrbringens |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).